Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19

COVID-19 disease caused by the SARS-CoV-2 virus is characterized by dysregulation of effector T cells and accumulation of exhausted T cells. T cell responses to viruses can be corrected by adoptive cellular therapy using donor-derived virus-specific T cells. One approach is the establishment of bank...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Rachel S., Fraser, Alasdair R., Smith, Linda, Burgoyne, Paul, Imlach, Stuart N., Jarvis, Lisa M., Turner, David M., Zahra, Sharon, Turner, Marc L., Campbell, John D. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819874/
https://www.ncbi.nlm.nih.gov/pubmed/33488592
http://dx.doi.org/10.3389/fimmu.2020.598402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819874/
https://www.ncbi.nlm.nih.gov/pubmed/33488592
http://dx.doi.org/10.3389/fimmu.2020.598402

Ejemplares similares